Alnylam Pharmaceuticals
ALNY
$148.43
Share price
-1.07%
Change (1 day)
-21.33%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Stock price history for Alnylam Pharmaceuticals (ALNY)
Highest end of day price: $241.31 USD on 2022-12-21
Lowest end of day price: $3.95 USD on 2004-08-16
Stock price history of Alnylam Pharmaceuticals from 2004 to 2024
Stock price for similar companies or competitors
| Company | Stock price | Change 1d% | Country |
|---|---|---|---|
 Novartis NVS | $103.13 | 2.41% | 🇨🇭 Switzerland |
 Sanofi SNY | $49.03 | 2.51% | 🇫🇷 France |
 Regeneron Pharmaceuticals REGN | $980.16 | 1.06% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $129.86 | 4.35% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $2.29 | 1.33% | 🇺🇸 USA |
 OPKO Health
OPK | $1.37 | -2.84% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $16.93 | 0.18% | 🇮🇱 Israel |
 Arrowhead Pharmaceuticals
ARWR | $22.95 | 0.75% | 🇺🇸 USA |